Augmented Renal Clearance in the ICU: Estimation, Incidence, Risk Factors and Consequences-a Retrospective Observational Study

Overview

Journal Ann Intensive Care

Specialty Critical Care

Date 2022 Sep 26

PMID 36156744

Authors

Alexandre Egea

Claire Dupuis

Etienne de Montmollin

Paul-Henry Wicky

Juliette Patrier

Pierre Jaquet

Lucie Lefevre

Fabrice Sinnah

Mehdi Marzouk

Romain Sonneville

Lila Bouadma

Bertrand Souweine

Jean-Francois Timsit

Affiliations

Soon will be listed here.

Abstract

Background: Augmented renal clearance (ARC) remains poorly evaluated in ICU. The objective of this study is to provide a full description of ARC in ICU including prevalence, evolution profile, risk factors and outcomes.

Methods: This was a retrospective, single-center, observational study. All the patients older than 18 years admitted for the first time in Medical ICU, Bichat, University Hospital, APHP, France, between January 1, 2017, and November 31, 2020 and included into the Outcomerea database with an ICU length of stay longer than 72 h were included. Patients with chronic kidney disease were excluded. Glomerular filtration rate was estimated each day during ICU stay using the measured creatinine renal clearance (CrCl). Augmented renal clearance (ARC) was defined as a 24 h CrCl greater than 130 ml/min/m.

Results: 312 patients were included, with a median age of 62.7 years [51.4; 71.8], 106(31.9%) had chronic cardiovascular disease. The main reason for admission was acute respiratory failure (184(59%)) and 196(62.8%) patients had SARS-COV2. The median value for SAPS II score was 32[24; 42.5]; 146(44%) and 154(46.4%) patients were under vasopressors and invasive mechanical ventilation, respectively. The overall prevalence of ARC was 24.6% with a peak prevalence on Day 5 of ICU stay. The risk factors for the occurrence of ARC were young age and absence of cardiovascular comorbidities. The persistence of ARC during more than 10% of the time spent in ICU was significantly associated with a lower risk of death at Day 30.

Conclusion: ARC is a frequent phenomenon in the ICU with an increased incidence during the first week of ICU stay. Further studies are needed to assess its impact on patient prognosis.

Citing Articles

Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation.

Chen L, Wang C, Lin C, Tsai M, Shen W, Li P Infect Drug Resist. 2024; 17:4195-4203.

PMID: 39355780 PMC: 11444064. DOI: 10.2147/IDR.S477414.

Managing Modern Antiretroviral Therapy in the Intensive Care Unit: Overcoming Challenges for Critically Ill People With Human Immunodeficiency Virus.

Chastain D, Tu P, Brizzi M, Keedy C, Baker A, Jackson B Open Forum Infect Dis. 2024; 11(5):ofae213.

PMID: 38715574 PMC: 11075789. DOI: 10.1093/ofid/ofae213.

Model-Informed Precision Dosing of Imipenem in an Obese Adolescent Patient with Augmented Renal Clearance and History of Schizophrenia.

Chen Y, Han Y, Guo F, Yu Z Infect Drug Resist. 2024; 17:761-767.

PMID: 38433781 PMC: 10908274. DOI: 10.2147/IDR.S450294.

Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.

Wu Y, Lu Z, Liang P, Zhu H, Qi H, Zhang H Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(7):4791-4798.

PMID: 38153513 DOI: 10.1007/s00210-023-02909-4.

Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children.

Dhont E, Van Der Heggen T, Snauwaert E, Willems J, Croubels S, Delanghe J Pediatr Nephrol. 2023; 39(5):1607-1616.

PMID: 37994980 DOI: 10.1007/s00467-023-06221-4.

References

Udy A, Roberts J, Lipman J . Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol. 2011; 7(9):539-43. DOI: 10.1038/nrneph.2011.92. View

Cook A, Hatton-Kolpek J . Augmented Renal Clearance. Pharmacotherapy. 2019; 39(3):346-354. DOI: 10.1002/phar.2231. View

Carrie C, Petit L, dHoudain N, Sauvage N, Cottenceau V, Lafitte M . Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study. Int J Antimicrob Agents. 2017; 51(3):443-449. DOI: 10.1016/j.ijantimicag.2017.11.013. View

Wu C, Tai C, Liao W, Wang C, Kuo C, Lin S . Augmented renal clearance is associated with inadequate antibiotic pharmacokinetic/pharmacodynamic target in Asian ICU population: a prospective observational study. Infect Drug Resist. 2019; 12:2531-2541. PMC: 6701640. DOI: 10.2147/IDR.S213183. View

Minville V, Asehnoune K, Ruiz S, Breden A, Georges B, Seguin T . Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study. Crit Care. 2011; 15(1):R49. PMC: 3221979. DOI: 10.1186/cc10013. View

Udy A, Baptista J, Lim N, Joynt G, Jarrett P, Wockner L . Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*. Crit Care Med. 2013; 42(3):520-7. DOI: 10.1097/CCM.0000000000000029. View

Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W . Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009; 35(10):1692-702. DOI: 10.1007/s00134-009-1530-4. View

Bakke V, Sporsem H, von der Lippe E, Nordoy I, Lao Y, Nyrerod H . Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study. Acta Anaesthesiol Scand. 2017; 61(6):627-635. PMC: 5485054. DOI: 10.1111/aas.12897. View

Udy A, Varghese J, Altukroni M, Briscoe S, McWhinney B, Ungerer J . Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest. 2011; 142(1):30-39. DOI: 10.1378/chest.11-1671. View

10.

Carlier M, Dumoulin A, Janssen A, Picavet S, Vanthuyne S, Van Eynde R . Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med. 2015; 41(3):427-35. DOI: 10.1007/s00134-014-3641-9. View

11.

Minkute R, Briedis V, Steponaviciute R, Vitkauskiene A, Maciulaitis R . Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin. J Clin Pharm Ther. 2013; 38(6):462-7. DOI: 10.1111/jcpt.12088. View

12.

Campassi M, Gonzalez M, Masevicius F, Risso Vazquez A, Moseinco M, Navarro N . [Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment]. Rev Bras Ter Intensiva. 2014; 26(1):13-20. PMC: 4031886. DOI: 10.5935/0103-507x.20140003. View

13.

Wilson R, Soullier G . The validity of two-hour creatinine clearance studies in critically ill patients. Crit Care Med. 1980; 8(5):281-4. DOI: 10.1097/00003246-198005000-00002. View

14.

Claus B, Hoste E, Colpaert K, Robays H, Decruyenaere J, De Waele J . Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013; 28(5):695-700. DOI: 10.1016/j.jcrc.2013.03.003. View

15.

Fuster-Lluch O, Geronimo-Pardo M, Peyro-Garcia R, Lizan-Garcia M . Glomerular hyperfiltration and albuminuria in critically ill patients. Anaesth Intensive Care. 2008; 36(5):674-80. DOI: 10.1177/0310057X0803600507. View

16.

De Waele J, Dumoulin A, Janssen A, Hoste E . Epidemiology of augmented renal clearance in mixed ICU patients. Minerva Anestesiol. 2015; 81(10):1079-85. View

17.

Mulder M, Eidelson S, Sussman M, Schulman C, Lineen E, Iyenger R . Risk Factors and Clinical Outcomes Associated With Augmented Renal Clearance in Trauma Patients. J Surg Res. 2019; 244:477-483. DOI: 10.1016/j.jss.2019.06.087. View

18.

Herrera-Gutierrez M, Seller-Perez G, Banderas-Bravo E, Munoz-Bono J, Lebron-Gallardo M, Fernandez-Ortega J . Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study. Intensive Care Med. 2007; 33(11):1900-6. DOI: 10.1007/s00134-007-0745-5. View

19.

Ollivier J, Carrie C, dHoudain N, Djabarouti S, Petit L, Xuereb F . Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?. Antimicrob Agents Chemother. 2019; 63(3). PMC: 6395919. DOI: 10.1128/AAC.02134-18. View

20.

Brown R, Babcock R, Talbert J, Gruenberg J, Czurak C, Campbell M . Renal function in critically ill postoperative patients: sequential assessment of creatinine osmolar and free water clearance. Crit Care Med. 1980; 8(2):68-72. DOI: 10.1097/00003246-198002000-00004. View